| Immune responses in kala-azar S Saha, S Mondal, A Banerjee, J Ghose, S Bhowmick, N Ali Indian Journal of Medical Research 123 (3), 245, 2006 | 125 | 2006 |
| Complete cure of experimental visceral leishmaniasis with amphotericin B in stearylamine-bearing cationic liposomes involves down-regulation of IL-10 and favorable T cell responses A Banerjee, M De, N Ali The Journal of Immunology 181 (2), 1386-1398, 2008 | 83 | 2008 |
| Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines A Banerjee, P Bhattacharya, AB Joshi, N Ismail, R Dey, HL Nakhasi Cellular immunology 309, 37-41, 2016 | 82 | 2016 |
| Leu432Val polymorphism in CYP1B1 as a susceptible factor towards predisposition to primary open-angle glaucoma A Bhattacharjee, D Banerjee, S Mookherjee, M Acharya, A Banerjee, ... Molecular vision 14, 841, 2008 | 70 | 2008 |
| Live attenuated Leishmania donovani centrin gene–deleted parasites induce IL-23–dependent IL-17–protective immune response against visceral leishmaniasis in a murine model A Banerjee, P Bhattacharya, PK Dagur, S Karmakar, N Ismail, AB Joshi, ... The Journal of Immunology 200 (1), 163-176, 2018 | 62 | 2018 |
| Association of IL1A and IL1B loci with primary open angle glaucoma S Mookherjee, D Banerjee, S Chakraborty, A Banerjee, I Mukhopadhyay, ... BMC medical genetics 11, 1-9, 2010 | 50 | 2010 |
| Stearylamine-bearing cationic liposomes kill Leishmania parasites through surface exposed negatively charged phosphatidylserine A Banerjee, J Roychoudhury, N Ali Journal of antimicrobial chemotherapy 61 (1), 103-110, 2008 | 50 | 2008 |
| Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation A Banerjee, M De, N Ali Antimicrobial agents and chemotherapy 55 (4), 1661-1670, 2011 | 49 | 2011 |
| Mitochondrial genome analysis of primary open angle glaucoma patients D Banerjee, A Banerjee, S Mookherjee, M Vishal, A Mukhopadhyay, ... PLoS One 8 (8), e70760, 2013 | 41 | 2013 |
| Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™ 10, a new liposomal amphotericin B M Asad, P Bhattacharya, A Banerjee, N Ali BMC infectious diseases 15, 1-12, 2015 | 36 | 2015 |
| Non-coding pDNA bearing immunostimulatory sequences co-entrapped with leishmanial antigens in cationic liposomes elicits almost complete protection against experimental … S Mazumder, R Ravindran, A Banerjee, N Ali Vaccine 25 (52), 8771-8781, 2007 | 35 | 2007 |
| Functional and structural analyses of CYP1B1 variants linked to congenital and adult-onset glaucoma to investigate the molecular basis of these diseases A Banerjee, S Chakraborty, A Chakraborty, S Chakrabarti, K Ray PloS one 11 (5), e0156252, 2016 | 34 | 2016 |
| Chlorogenic acid acts upon Leishmania donovani arresting cell cycle and modulating cytokines and nitric oxide in vitro N Majumder, S Ganguly, AK Ghosh, S Kundu, A Banerjee, S Saha Parasite Immunology 42 (6), e12719, 2020 | 14 | 2020 |
| A review on new natural and synthetic anti-leishmanial chemotherapeutic agents and current perspective of treatment approaches. N Majumder, A Banerjee, S Saha Acta Tropica 240, 106846, 2023 | 11 | 2023 |
| Combinatorial therapeutic trial plans for COVID-19 treatment armed up with antiviral, antiparasitic, cell-entry inhibitor, and immune-boosters N Roy Chattopadhyay, K Chatterjee, A Banerjee, T Choudhuri VirusDisease 31 (4), 479-489, 2020 | 6 | 2020 |
| Oral Treatment with Aqueous Solution of Coffea canephora Induce Protective Immune Response to Reduce Parasite Burden in Experimental Visceral Leishmaniasis S Saha, A Banerjee, A Verma, CK Jha Am J Phyt Clin Ther 2, 242-251, 2014 | 3 | 2014 |
